Big vein is a viral disease of lettuce (Lactuca sativa L.) transmitted by the soilborne fungus Olpidium brassicae (7). Symptoms of big vein include chlorosis surrounding the vascular bundles in the leaf and increased stiffness of the leaves. In iceberg lettuce, this can disrupt normal head development, resulting in plants that have a bushy appearance. The primary source of economic damage resulting from big vein disease is a reduction in the number of heads formed. Big vein is most prevalent in cool wet soils (4, 22, 23) , and increases with continuous lettuce production without rotation. Consequently, big vein consistently occurs at high levels during spring production in California's coastal growing districts, and during winter production in Arizona.
Effective long-term control of big vein disease is best accomplished through genetic resistance and is important for sustainable production of quality lettuce in California and Arizona, where 99% of U.S. lettuce production occurs (1). Complete resistance to big vein has only been identified in accessions of Lactuca virosa L. (2), but this resistance has not been introgressed into lettuce cultivars. Among cultivated lettuce, cultivars are available with partial resistance that can be measured by reduced frequency of symptomatic plants or symptom expression that is delayed until plants reach market maturity (15) . This type of resistance has greatly improved marketable yields in fields infested with big vein (14). Progress in increasing the level of partial resistance has been slow, primarily because of a lack of information regarding the pathogen, the unknown inheritance of resistance, and the large influence that environmental conditions have on symptom expression.
Although big vein disease has affected lettuce production for many years, the causal agent, Mirafiori lettuce big-vein virus (MLBVV) (genus Ophiovirus), formerly known as Mirafiori lettuce virus, was only recently identified (8, 11 ). Another virus, Lettuce big-vein associated virus (LBVaV) (genus Varicosavirus), formerly known as Lettuce big-vein virus, was previously found associated with big vein disease, but a causative relationship was never confirmed (6,21). Interestingly, many studies have demonstrated that plants exhibiting big vein symptoms were frequently coinfected with both viruses, suggesting LBVaV may also contribute in some manner to the disease (9,10,12).
LBVaV and MLBVV both encode most of their proteins on the negative or complementary sense RNA (16, 20) . The genome of LBVaV is bipartite. RNA1 encodes an RNA-dependent RNA polymerase (16) , while RNA2 encodes five additional open reading frames, including the viral coat protein (CP) (17) . The genome of MLBVV contains four separate RNAs. The 48.5 kDa CP is encoded on RNA3 (20) . By comparing viral CP nucleotide sequences, Navarro et al. (10) demonstrated that LBVaV isolates from lettuce in Europe were closely related to each other, and to several isolates from around the world. European MLBVV isolates were also found to be highly conserved; however, these isolates could be separated into two subgroups.
Understanding the distribution of MLBVV and LBVaV in California and the genetic relationships among virus isolates in this region is important for the development of control methods suitable for production conditions in the western United States. Additionally, knowledge of the virus or viruses responsible for big vein disease may facilitate development of more effective resistance screening methods and identification of plants not only with reduced symptom expression, but also with reduced virus infection. The objectives of this research were to determine (i) the frequency of MLBVV and LBVaV infection in California field-grown lettuce, (ii) the frequency of MLBVV and LBVaV infection in greenhouse-inoculated L. sativa cultivars and L. virosa breeding material, and (iii) the sequence diversity of MLBVV and LBVaV isolates from California.
MATERIALS AND METHODS
Collection of field samples and classification of symptom severity. Lettuce leaf samples were collected for virus RNA isolation from field sites in the California central-coast production area. Commercial lettuce fields (cultivars unknown) were arbitrarily chosen for sampling from diverse sites within a 3,600 km 2 region covering three lettuce-growing districts. Seven locations were sampled throughout the Salinas Valley, including two near Salinas, and from sites near Chualar, Gonzales, Soledad, Greenfield, and King City. Individual locations were also sampled near San Juan Bautista in the Santa Clara Valley and Watsonville in the Pajaro Valley. One field was chosen per location, and five to nine plants per field were sampled by collecting one complete leaf per plant. Leaves were stored on ice, brought into the lab, and classified as healthy, mild, moderate, or severe for big vein symptoms using the disease severity scale illustrated in Figure   1 . Lettuce tissue was sampled (100 mg per sample), lyophilized, and stored at -80°C prior to RNA extraction. (15) . Seedlings were germinated in a potting mix containing a 2:1 Fig. 1 . Big vein symptoms on iceberg (left column) and romaine (right column) lettuce leaves. Healthy = no symptoms. Mild = narrow vein clearing and/or symptoms occurring on less than 50% of the leaf area. Moderate = both wide and narrow vein clearing, symptoms occurring on more than 51% of the leaf area, slight shortening and stiffening of the leaf. Severe = wide vein clearing occurring on 100% of the leaf, pronounced shortening and stiffening of the leaf. ratio of field soil to sand, and grown for 3 weeks. A suspension of O. brassicae zoospores at greater than 30,000 zoospores per ml was prepared by collecting big vein symptomatic plants produced at the USDA-ARS research station in Salinas, CA, and macerating the roots in water. The seedlings were inoculated by watering the zoospore suspension into the seedling pots two times with each inoculation, separated by 48 h. Each seedling was subsequently transplanted into an 8-cm pot containing infested field soil. Plants were grown in a greenhouse maintained at 18°C, and the percentage of symptomatic plants was recorded after 6 to 8 weeks of growth. Tissue was sampled from asymptomatic and symptomatic plants from the third experiment for RNA extraction.
Reverse transcription-polymerase chain reaction (RT-PCR), sequencing, and diversity analysis. Tissue samples were ground in liquid nitrogen, and total RNA was extracted using the Qiagen RNeasy Plant Mini Kit (Qiagen Inc., Valencia, CA) according to the manufacturer's recommendations. RNA extracts were stored at -80°C. MLBVV PCR primer pairs (Table 1) were designed from published MLBVV and LBVaV nucleotide sequences. Amplicons were generated by RT-PCR from within each of the four MLBVV RNAs, from the CP region of LBVaV encoded near the 5′ end of the virus-complementary sense RNA2, as well as from a region near the 3′ end of ORF 5, encoded near the 3′ end of the viruscomplementary sense RNA2 (17) . RNA extracts (as well as positive and negative controls, and reagent blanks) were reversetranscribed using MMLV reverse transcriptase (Promega, Inc., Madison, WI) with reaction conditions of 37°C for 90 min, and cDNA was amplified with Taq DNA polymerase (Promega). Amplification conditions consisted of 5 min denaturation at 95°C, followed by 35 cycles of 95°C for 1 min, 50 to 56°C (depending on primer annealing temperature) for 1 min, and 72°C for 1 min, with a final extension at 72°C for 10 min. RT-PCR reaction products were separated by electrophoresis on 1% agarose gels and stained with ethidium bromide to determine the presence or absence of target bands. All samples from which MLBVV or LBVaV RNA did not amplify were re-analyzed using primer pairs made to other regions of the respective viral genomes (Table 1) , to rule out the occurrence of false negatives.
Nucleic acid hybridizations were used to confirm positive and negative results from some samples. Clones for probe synthesis and detection of MLBVV were constructed by cloning the amplification product of primers 829F and 1418R (Table 1) on isolate SJ6 obtained from a field near San Juan Bautista, CA. This region encoded a portion of the CP gene of MLBVV. Clones for use as probes for the detection of LBVaV were constructed by cloning the amplification product of primers 42F and 426R (Table 1) on isolate D3 obtained from a field near Salinas, CA. This region encoded a portion of the CP gene of LBVaV. Cloning methods were as described below. Probes were synthesized by in vitro transcription using T7 and SP6 promoters and labeling with the DIG RNA Labeling Kit (Roche, Indianapolis, IN). Hybridization and detection involved standard procedures as recommended by Roche.
Nucleic acid sequence diversity. DNA sequencing was performed on one sample from each field. Regions of all four MLBVV RNAs and two regions of LBVaV RNA2 were sequenced for each sample. RT-PCR was performed on these samples using primers with 5′-M13 tails (Table 1) . PCR products were purified prior to sequencing with Qiagen kits (QIAquick PCR Purification Kit, or QIAquick Gel Extraction Kit; Qiagen). DNA sequencing was also performed on clones of PCRamplified products for comparison with sequences generated directly from PCR products. PCR products (one from each of the amplified regions) were cloned using the TOPO TA Cloning Kit (pCR II-TOPO, Invitrogen, Carlsbad, CA) and used to transform Escherichia coli (either TOP10 cells, Invitrogen, or NovaBlue cells, EMD Biosciences, Madison, WI) using standard conditions. Plasmids were prepared with the Qiagen Plasmid Mini Kit prior to sequencing.
Sequencing reactions were performed on purified PCR products or plasmids with the USB Cycle Sequencing Kit (USB, Cleveland, OH), using ddNTP termination mixes, and with LI-COR IRDye-labeled M13 primers (LI-COR Inc., Lincoln, NE). Sequence data were generated using the LI-COR Global Edition IR 2 System and LI-COR eSeq software (v. 3.0). Some samples were sequenced by MCLab (South San Francisco, CA).
Statistical analysis. Chi-square goodness-of-fit was used to test dependence between big vein symptom expression and frequency of infection with MLBVV, LBVaV, coinfection of MLBVV and LBVaV, and the frequency of big vein symptomatic plants among lettuce genotypes. When analyzing frequencies from field samples, data were pooled within each severity class across all sampling locations. Likewise, data from greenhouse experiments were pooled across inoculations for each genotype. The degree of dependence was calculated according to the method of Steele and Torrie (18) . Nucleotide sequence assembly and analysis were conducted using the MacVector 7.0 software (Accelrys Inc., San Diego, CA). Alignments were conducted using ClustalW (19) .
RESULTS
The frequency of MLBVV and LBVaV was dependent on big vein symptom expression from naturally infected plants collected from the field ( Table 2) 
and moderate symptoms was 100%, but only 88% in plants with severe symptoms. In all, the degree of dependence between big vein symptoms and MLBVV (degree of dependence = 0.70) was five times greater than the degree of dependence between big vein symptoms and LBVaV (degree of dependence = 0.14).
Coinfection of LBVaV and MLBVV occurred in 79% of plants, and was a significant association compared with random distribution of each virus (Table 3 ). All plants with coinfection were symptomatic, but there was no statistically significant relationship between symptom severity and coinfection due to the high frequency of coinfection. Only five samples tested negative for both viruses, all of which were asymptomatic. Seven plants were positive for LBVaV and negative for MLBVV; all of these plants were asymptomatic. Three plants were positive for MLBVV and negative for LBVaV; all three were symptomatic.
Inoculation with O. brassicae zoospores from symptomatic plants resulted in significantly different percentages of symptomatic plants among Great Lakes 65, Margarita, and Pavane in experiment 1 (Table 4) . In experiment 2, Great Lakes 65, Pavane, and L. virosa accession IVT280 also had significantly different percentages of symptomatic plants (Table 4) . Importantly, all plants of L. virosa accession IVT280 remained asymptomatic. Detection of MLBVV and LBVaV with RT-PCR confirmed virus infection or coinfection in symptomatic greenhouse-grown lettuce cultivars from experiment 3, and virus infection patterns paralleled the results from field samples (Table 5 ). All five symptomatic Great Lakes 65 plants were coinfected with both MLBVV and LBVaV. Among symptomatic Margarita, three plants were positive for MLBVV and three were coinfected with MLBVV and LBVaV. Infection by LBVaV alone could not be detected in any symptomatic plant of any cultivar (Table 5) . LBVaV infection and MLBVV/LBVaV coinfection were detected in two asymptomatic plants of Great Lakes 65. Seven plants of Margarita remained asymptomatic. Of these, one plant was positive for both MLBVV and LBVaV, three plants were positive for LBVaV alone, and three plants were negative for both viruses. In all, six of the seven asymptomatic Margarita plants were MLBVV negative. All 14 plants of L. virosa IVT280 remained asymptomatic, and no MLBVV or LBVaV was detected in any plants of accession IVT280 (Table 5) .
Representative samples of symptomatic lettuce collected from fields located throughout the Salinas Valley (CA) and adjacent lettuce production areas were (Tables 6 and 7 ). The California isolates and the lone Arizona isolate YGV1 for which sequence information was available should be classified into MLBVV subgroup B (10) due to higher sequence similarity between these isolates and representative subgroup B isolates MUR1, LS301-O, GER2, Japan, and ITA1, compared to lower sequence similarity with subgroup A representative ALM1 (Table 6) . Analysis of the partial LBVaV CP amplicon (302 nt) and the ORF5 amplicon (310 nt) also revealed a high degree of nucleotide identity among LBVaV isolates from California. The LBVaV CP amplicon varied from 95.8 to 100% identical at the nucleotide level among the California isolates, with a mean identity of 97.9% when amplicon sequences were compared among the isolates individually. The LBVaV ORF5 amplicon shared 93.8 to 100% nucleotide identity with a mean identity of 97.6% among nine isolates. LBVaV isolates from California were also highly similar to those from Japan and Europe, sharing 96.8 to 98.7% identity with similar sequences of those isolates (Tables 6 and 7) .
DISCUSSION
Research on control of big vein disease has been limited by a lack of knowledge regarding the pathogen. Consequently, discovery of MLBVV in big vein symptomatic tissue, and its later report as the causal agent of big vein, was an important breakthrough for big vein research. Determining the occurrence of MLBVV in symptomatic lettuce and understanding the nucleotide sequence diversity of MLBVV isolates are important steps toward furthering big vein research in western U.S. production regions. Our research corroborates previous reports (9,12), showing a strong dependence between big vein symptom expression and MLBVV presence in California-grown lettuce. Additionally, coinfection with both MLBVV and LBVaV was common, and is presumed to result from a shared vector (8). These results are consistent with the findings of Lot et al. (8), that MLBVV is the causal agent of big vein disease.
MLBVV isolates collected from California were highly conserved throughout a sampling area ranging over 3,600 km 2 , and this conservation was present in amplicons from all four MLBVV RNAs. Nucleotide sequences of MLBVV amplicons vary from 94.2 to 100% for RNA1, to 97.5 to 100% for RNAs 3 and 4. Similarly, amplicons from both the CP region and a region near the 3′ end of LBVaV ORF5 also exhibited a high degree of conservation throughout the sampling area. In recent studies, Navarro et al. (10) compared se- a Isolate origins and accession numbers are listed in Table 7 . The high degree of nucleotide sequence conservation in both viruses demonstrated in this paper and by others (10,13) suggests that research on big vein disease resistance in the United States, Europe, and Japan will likely be relevant for lettuce production in other areas as well, due to nucleotide sequence conservation among lettuce isolates of these pathogens. Currently, no genotype of L. sativa has been identified as immune to big vein (2,15). Consequently, resistance to big vein disease in cultivated lettuce has been defined in terms of the number of days to symptom expression, or the proportion of symptomatic plants at market maturity (15) . Our research demonstrates this principle, with the cultivars Margarita and Pavane (considered resistant) having nearly two-thirds fewer symptomatic plants than the susceptible cultivar Great Lakes 65 (Table 4) . However, our research also demonstrates that symptomatic and asymptomatic plants from both resistant and susceptible L. sativa cultivars can accumulate MLBVV and LBVaV (Table 5 ). The mechanism of resistance in cultivated lettuce is not known, and more research is needed to determine the relative role of virus resistance and symptom expression in big vein resistance.
Among wild relatives of lettuce, only accessions of L. virosa have demonstrated a complete lack of symptom expression in inoculation trials (2). L. virosa accession IVT280 was identified as 100% asymptomatic in the greenhouse inoculation trials reported here. Analysis by RT-PCR demonstrated no viral amplification, indicating apparent immunity in this accession (Table  5) 
